Adjuvant radiotherapy cuts PCa death risk in higher risk patients

Prostate cancer patients with 2 or more adverse pathologic characteristics found at radical prostatectomy may benefit the most from adjuvant radiotherapy (aRT) in terms of reduced risk of cancer-specific mortality, researchers concluded in a poster presentation at the European Association of Urology 29th annual congress.

Renal & Urology News